BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36385713)

  • 1. Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.
    Zetner D; Kamby C; Gülen S; Christophersen C; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
    J Pineal Res; 2023 Jan; 74(1):e12840. PubMed ID: 36385713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double-blind, randomized, placebo-controlled trial.
    Zetner D; Kamby C; Christophersen C; Gülen S; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
    J Pineal Res; 2023 Aug; 75(1):e12873. PubMed ID: 37055944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin Supplementation for Cancer-Related Fatigue in Patients With Early Stage Breast Cancer Receiving Radiotherapy: A Double-Blind Placebo-Controlled Trial.
    Mukhopadhyay ND; Khorasanchi A; Pandey S; Nemani S; Parker G; Deng X; Arthur DW; Urdaneta A; Del Fabbro E
    Oncologist; 2024 Feb; 29(2):e206-e212. PubMed ID: 37699115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
    Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
    Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
    Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
    BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
    Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
    Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
    Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
    Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes.
    Chen WY; Giobbie-Hurder A; Gantman K; Savoie J; Scheib R; Parker LM; Schernhammer ES
    Breast Cancer Res Treat; 2014 Jun; 145(2):381-8. PubMed ID: 24718775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependent sun protective effect of topical melatonin: A randomized, placebo-controlled, double-blind study.
    Scheuer C; Pommergaard HC; Rosenberg J; Gögenur I
    J Dermatol Sci; 2016 Nov; 84(2):178-185. PubMed ID: 27543364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
    Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
    Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
    Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
    Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.
    Shariati L; Amouheidari A; Naji Esfahani H; Abed A; Haghjooy Javanmard S; Laher I; Ghasemi A; Vaseghi G
    Br J Clin Pharmacol; 2020 Sep; 86(9):1875-1881. PubMed ID: 32040868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of spleen aminopeptide oral lyophilized powder for improving quality of life and immune response in patients with advanced breast cancer: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Wang J; Ma X; Shang K; Wu S; Ma Y; Ma Z; Cao B
    Anticancer Drugs; 2021 Nov; 32(10):1067-1075. PubMed ID: 34261911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
    Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
    Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Pilot Study of a Keratin-based Topical Cream for Radiation Dermatitis in Breast Cancer Patients.
    Winkfield KM; Hughes RT; Brown DR; Clohessy RM; Holder RC; Russell GB; Rejeski AF; Burnett LR
    Technol Cancer Res Treat; 2024; 23():15330338231222137. PubMed ID: 38186361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.